A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: the treat-to-target (3T) study.

Source:http://linkedlifedata.com/resource/pubmed/id/12637115

Download in:

View as

General Info

PMID
12637115